REPOZYTORIUM UNIWERSYTETU
W BIAŁYMSTOKU
UwB

Proszę używać tego identyfikatora do cytowań lub wstaw link do tej pozycji: http://hdl.handle.net/11320/18168
Tytuł: The interferon-induced helicase C domain-containing protein 1 gene variant (rs1990760) as an autoimmune-based pathology susceptibility factor
Autorzy: Wawrusiewicz-Kurylonek, Natalia
Gościk, Joanna
Chorąży, Monika
Siewko, Katarzyna
Posmyk, Renata
Zajkowska, Agata
Citko, Anna
Maciulewski, Rafał
Szelachowska, Małgorzata
Myśliwiec, Janusz
Jastrzębska, Izabella
Kułakowska, Alina
Kochanowicz, Jan
Krętowski, Adam Jacek
Słowa kluczowe: IFIH1 gene
Graves’ disease
Multiple sclerosis
LADA diabetes
Polymorphism
Data wydania: 2020
Data dodania: 4-kwi-2025
Wydawca: Elsevier
Źródło: Immunobiology, Volume 225, Issue 1, 2020, 151864
Abstrakt: Purpose: Autoimmune diseases are a group of complex diseases localized in multiple organ systems, with a wide spectrum of symptoms and still unclear causes. The aim of the present study was to analyse a possible association of three autoimmune disabilities - Multiple sclerosis (MS), LADA diabetes and Graves’ disease (GD) with single nucleotide polymorphism (SNP; rs1990760) in the IF IH1 gene (also known as a melanoma differentiation-associated protein 5 - MDA5) within the Polish population. An additional goal was also to look for a correlation between this polymorphism and different clinical patient-related factors. Materials and methods: The study population consisted of four groups of 944 unrelated Polish origin Caucasian patients – 324 with GD, 171 with MS, 49 with LADA diabetes and 400 healthy subjects as a control group. The SNP analysis was performed using the allelic discrimination technique. Results & Conclusions: There were significant associations of risk T allel of the analyzed polymorphism with all studied autoimmune diseases (GDeOR = 1.34, p = 7.02e-03; MSeOR = 1.36, p = 2.17e-02; LADA – OR = 3.36, p = 8.73e-07). We also found that the frequency of CT and TT genotypes of the rs1990760 IFIH1 gene only in females (with LADA, GD, MS) was significantly higher than those in the female control group (47%, 41% vs 44%, 34%; p = 1.32e-03, p = 4.39e-04; OR = 2.08, 95%CI: (1.33–3.28), OR = 2.29, 95% CI: (1.44–3.65) respectively). Our research has shown significant differences regarding some clinical features (BMI, TRAb, TSH, HbA1C, anti-GAD antibodies) and age at the beginning of the studied autoimmune disabilities. This study showed an association of rs1990760 polymorphism in the IFIH1 gene in the development of GD, LADA diabetes and MS within the Polish population. To our knowledge, this is the first study to investigate the relationship between IFIH1 polymorphisms and the risk of the development of MS and LADA in Poland.
Afiliacja: Natalia Wawrusiewicz-Kurylonek - Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, Sklodowska – Curie 24A, 15-276, Bialystok, Poland
Joanna Gościk - Faculty of Computer Science Bialystok University of Technology, Wiejska 45A, 15-351 Bialystok, Poland
Monika Chorąży - Department of Neurology, Medical University of Bialystok, Sklodowska – Curie 24A, 15-276, Bialystok, Poland
Katarzyna Siewko - Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, Sklodowska – Curie 24A, 15-276, Bialystok, Poland
Renata Posmyk - Department of Clinical Genetics, Medical University of Bialystok, Waszyngtona 14, 15-089, Bialystok, Poland
Agata Zajkowska - Department of Neurology, Medical University of Bialystok, Sklodowska – Curie 24A, 15-276, Bialystok, Poland
Anna Citko - Clinical Research Centre, Medical University of Bialystok, Sklodowska – Curie 24A, 15-276, Bialystok, Poland
Rafał Maciulewski - Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, Sklodowska – Curie 24A, 15-276, Bialystok, Poland
Małgorzata Szelachowska - Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, Sklodowska – Curie 24A, 15-276, Bialystok, Poland
Janusz Myśliwiec - Department of Nuclear Medicine, Medical University of Bialystok, Sklodowska – Curie 24A, 15-276, Bialystok, Poland
Izabella Jastrzębska - Faculty of Chemistry, University of Bialystok, Ciołkowskiego 1K, 15-245, Białystok, Poland
Alina Kułakowska - Department of Neurology, Medical University of Bialystok, Sklodowska – Curie 24A, 15-276, Bialystok, Poland
Jan Kochanowicz - Department of Neurology, Medical University of Bialystok, Sklodowska – Curie 24A, 15-276, Bialystok, Poland
Adam Jacek Krętowski - Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, Sklodowska – Curie 24A, 15-276, Bialystok, Poland; Clinical Research Centre, Medical University of Bialystok, Sklodowska – Curie 24A, 15-276, Bialystok, Poland
E-mail: Natalia Wawrusiewicz-Kurylonek: natalia.wawrusiewicz-kurylonek@umb.edu.pl
URI: http://hdl.handle.net/11320/18168
DOI: 10.1016/j.imbio.2019.10.013
e-ISSN: 1878-3279
Typ Dokumentu: Article
metadata.dc.rights.uri: https://creativecommons.org/licenses/by-nc-nd/4.0/
Właściciel praw: © 2019 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license
Występuje w kolekcji(ach):Artykuły naukowe (WChem)

Pliki w tej pozycji:
Plik Opis RozmiarFormat 
N_Wawrusiewicz_Kurylonek_J_Goscik_I_Jastrzebska_at_al_The_interferon_induced_helicase_C.pdf791,27 kBAdobe PDFOtwórz
Pokaż pełny widok rekordu Zobacz statystyki


Pozycja ta dostępna jest na podstawie licencji Licencja Creative Commons CCL Creative Commons